Approval · Notice of Compliance 13459 · 2012
FORTEO: Notice of Compliance 13459
Issued July 4, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13459
- Date
- July 4, 2012
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Bone Formation Agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FORTEO | Not yet assigned | — |
Medicinal ingredients
- TERIPARATIDE 250 MCG per ML